Microgenesis
San Francisco
About Microgenesis
Microgenesis offers a new fertility test and personalized nutritional supplementation that restores the fertility potential of women everywhere. Microgenesis has proven their validity in tough cases – women who have already failed multiple IVF implantations. Now, they are bringing their solution downmarket to OB-GYNs and D2C, operating out of a CLIA lab in Oakland. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Their three-month treatment is drug-free and all-natural.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $2.2M
- Funding stage: Seed
- Last round: Convertible Note (Aug 2021)
- Website: microgenesis.net
- Phone: 4158513540
Industries & Categories
Biotechnology, Fertility, Health Care, Health Diagnostics, Women's
Social Profiles
Canonical: https://fsome.com/organization/microgenesis-74332 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.